Revelation Biosciences Inc Sustainability Reports
Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates are based on the Gemini formulation of phosphorylated hexaacyl disaccharide (PHAD) designed to harness the power of trained immunity.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300UKS15BEXENY615
FIGI: BBG00WH4GC08
2 reports from 2021 to 2022